Statistics from Altmetric.com
Ring dermoid of the cornea (RDC, MIM180550) is an autosomal dominantly inherited syndrome characterised by bilateral annular limbal dermoids with corneal and conjunctival extension. The genetic basis of RDC is unknown. We report linkage of chromosome 4q24-q26 to RDC and identification of a missense mutation in PITX2 in 17 disease affected individuals but not in eight genetically related normal individuals in a large Chinese family.
A large Chinese family with 17 individuals affected by the RDC was identified (figs 1 and 2). All patients were diagnosed by the same physician (XHX). Informed written consent for blood sample collection was obtained from all participants.
Linkage analysis and genotyping were done essentially as previously described.1 Genome-wide screening was carried out with 382 microsatellite markers covering all autosomal chromosomes, with an average interval of 10 cM (ABI PRISM™ linkage mapping set, version 2.0). Fine mapping was accomplished using fluorescent labelled primers from the Marshfield database. Alleles were analysed by GeneScan analysis, version 3.0 software, and Genotyper, version 2.1 software (ABI PRISM™ linkage analysis and haplotype construction). Two point linkage analysis was conducted using the MLINK program of the Linkage 5.1 package (Rockefeller University, New York, USA). The disease allele frequency was set at 0.0001 with the recombination fraction (θ) in male and female subjects considered equal. The penetrance frequency of the disease was assumed to be 0.99 with autosomal dominance. The most likely haplotype was constructed by the Cyrillic program (Electrotechnical Laboratory, Tokyo, Japan).
The ring dermoid of the cornea (RDC, MIM180550) is an autosomal dominantly inherited syndrome characterised by bilateral annular limbal dermoids with corneal and conjunctival extension.
We report linkage of a 15 cM interval on chromosome 4q24-q26 to RDC. A missense mutation in PITX2 was found in 17 disease affected individuals but not in eight genetically related normal individuals in a large Chinese family, and in 157 normal unrelated individuals.
Given that PITX2 functions in eye development, these findings suggest mutations in PITX2 as a potential cause of RDC.
For mutation analysis, all exons and intron–exon boundaries of selected genes were amplified by polymerase chain reaction (PCR) using genomic DNA of the proband as template and primers designed according to the genomic sequences obtained from Genbank. Sequencing of the PCR products was automated (ABI3100 sequencer).
In this large Chinese family, 21 of 36 genetically linked individuals were affected by RDC.2 Patients showed yellow-white tumour-like apophyses (2–3 mm high and 3–5 mm wide) on the corneal border of both eyes (fig 1). The apophyses were clinically detectable at birth and progressively impaired the patients’ vision with aging. Some affected individuals also had glaucoma (II-2, III-4, and IV-3), unilateral cataracts (IV-3), or involuntary oscillation of the eyes (IV-3). The only clinical manifestation in the affected individuals were in the eyes. Consistent with previously reported autosomal dominantly inherited patterns of RDC, affected cases were found in both male and female descendants of each of four generations.
The linkage analysis was carried out with samples collected from 17 affected individuals, eight genetically related normal siblings, and seven genetically unrelated family members. Results showed a maximum two point lod score of 3.91 (θ = 0), 2.33 (θ = 0), and 1.87 (θ = 1) for D4S1572, D4S406, and D4S402, respectively. The results establish a linkage of RDC to chromosome 4q. Fine mapping using 12 microsatellite markers around D4S1572 and D4S406 identified a maximum two point lod score of 6.72 (θ = 0) for D4S2989. The lod scores for the neighbouring markers D4S2945 and D4S161 were 5.04 and 5.01 (θ = 0), respectively (table 1). Haplotype analysis for 14 markers on chromosome 4q showed that all affected family members were carriers of the risk haplotype (fig 2). Recombination between D4S1560 and D4S2966 was detected in affected individuals II-9 and III-15. Another recombination between D4S1613 and D4S1522 was found in affected individuals III-8 and IV-6. Most normal members of the family who were examined did not carry the haplotype. However, the genetically related normal individual II-11 carried a partial haplotype with a recombination between D4S1572 and D4S1570, suggesting that the candidate risk gene is located distal to D4S1572. Moreover, a genetically related normal individual, IV-2, carried the haplotype with a recombination between D4S1613 and D4S1522, where a recombination was detected in III-8 and IV-6. The results indicate that the candidate risk gene is located at the proximal side of D4S1522 (fig 2). Together, the haplotype between D4S1572 and D4S1522 co-segregates with the disease in this family. Thus a linkage of the RDC locus to a 15 cM interval between D4S1572 and D4S1522 was established.
The genomic interval between D4S1572 and D4S1522 contains 65 known genes and 56 reference genes. Three potential candidate genes for RDC were chosen for further mutation examination, based on both their tissue specific expression and their roles in regulating cell proliferation, differentiation, and migration that may play an important part in RDC pathogenesis.2 These include IDAX (NM 025212),3TM4SF9 (NM005723),4 and PITX2 (NM 153427).5 Mutation analysis showed no mutations in IDAX or TM4SF9 of the proband. A heterozygous mutation of guanine to adenine (185G→A) was detected in PITX2 of the proband (fig 3). Further sequence analysis showed a perfect segregation of this mutation with the disease in all 17 affected individuals in the family. Interestingly, affected individual III-12 showed a homozygous mutation. The mother of III-12 is an affected person harbouring a heterozygous G185A mutation, while the father is normal, with no mutation at nucleotide 185. Genetic analysis confirms that the father is the biological father (not shown). It is likely that III-12 carries a mutation inherited from the mother and a de novo mutation at the same position. No mutation of PITX2 was detected in eight genetically related normal individuals, seven genetically unrelated individuals in the family, and 150 ethnically appropriate normal controls. The results indicate that the sequence change observed is not a common polymorphism.
PITX2, a downstream target of wnt/β-catenin pathway, encodes a homeodomain transcription factor required for normal development of multiple organs, including eye, heart, and pituitary.6–13 Mutations in PITX2 are associated with multiple dominantly inherited diseases related to malfunction of the eyes, including Riger syndrome,5 iridogoniodysgenesis,14 iris hypoplasia,15 and Peter’s anomaly.16 This study suggests that mutation in PITX2 is linked to another eye disease. The PITX2 G185A mutation found in RDC patients is a novel disease associated mutation resulting in a substitution of arginine by histidine at amino acid 62 (R62H) located in the conserved DNA binding homeodomain (fig 4). The mutation probably results in changes in its transcriptional activity, as with other disease associated mutations identified in this gene.17–21 Identification of this novel mutation in PITX2 may reveal the molecular mechanism underlying the RDC pathology.
This study was supported by Chinese 973 projects (G1998051002 and 2001CB510302), 863 projects (2002BA711A07–08,03, Z19–02–02–02, 2001AA227011, and 2002BA711A08), the Chinese National Natural Science Foundation (39980018, 30070410, 30270735, and 30340078), the Cheung Kong Scholars Programme, and the Life Science Research Foundation of Hunan Province.
Conflicts of interest: none declared
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.